Mar 30

Type 2 diabetes is the most common form of diabetes and it increases risks for many serious health problems including neuropathy, high blood pressure, kidney disease, heart disease and stroke. Clinical inertia, failure to intensify treatment in a... [read more]

Mar 15

A biosimilar is a biological product that is “highly similar” to an FDA-approved reference biological product and has no “clinically meaningful differences.” Each biosimilar, with its distinct data package, approved indications, and routes of... [read more]

Feb 13

Roughly 15 percent of the adult population experiences chronic pain and about 3 percent of adults in the United States receive long-term opioid therapy for chronic noncancer pain. Commonly prescribed for their analgesic or pain-killing properties,... [read more]

Feb 1

Summary from December 2017 PT for MDs ... [read more]

Feb 1

FDA warnings about the increased effects of opioids and other drugs when taken with gabapentin has sparked a recent debate and research indicates a valid cause for the concern. When compared to those taking opioids alone, the risk of opioid-related... [read more]

Jan 16

Across the nation, diabetes is a growing economic burden, with annual treatment costs of $322 billion. Those with diabetes can expect healthcare costs to be 2.3 times greater than those without the disease. Due to high costs associated with management... [read more]

Jan 2

01022018 – New year, new formulary and Rx benefit concerns ... [read more]

Dec 15

The PILL Fiscally Aware Providers ... [read more]

Dec 1

Did you know that medication nonadherence affects health outcomes and overall healthcare costs? Fifty percent of the 187 million Americans who take one or more prescription drugs do not take their medication as prescribed. Click here to learn more... [read more]

Nov 15

Click to download the Herpes Zoster Vaccines Comparison   ... [read more]

« Previous Entries